Clinical Trial Update: Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated disulfiram with copper in combination with radiation therapy and temozolomide for newly diagnosed glioblastoma; the study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Disulfiram (Disulfiram)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Glioblastoma Multiforme | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-04-10